SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2827J Transl Med. 2012 Dec 11;10(1):247. [Epub ahead of print] Indoleamine 2,3-dioscaram(o)uche-1/11/2013
2826Cancer Cell. 2012 Dec 11;22(6):796-811. doi: 10.1016/j.ccr.2012.10.023. JAK2/Sscaram(o)uche-1/11/2013
2825I think that Peter found it, GILD's tipping point, when he pointed to the TBscaram(o)uche-1/10/2013
2824Extremely useful insights, for me. Thank you! Rickscaram(o)uche-12/14/2012
2823Pfizer has published and spoken quite a bit about tofa, but I don't think thtommysdad-12/13/2012
2822Cytopia was my first search term, jak2 was the second and last. Searched issuedscaram(o)uche-12/12/2012
2821>> CYT387 is of a bog-standard kinase inhibitor chemotype, unrelated to INscaram(o)uche-12/12/2012
2820Need to be a little careful with how one run's the searches. If memory servtommysdad212/12/2012
2819issued..... patft.uspto.gov filed, includes JAK3-specific methods, filed 1/12scaram(o)uche-12/12/2012
2818>> Would love to have his view on this, but I do not << Try drugs scaram(o)uche212/12/2012
2817Would be interesting to see the YMI patent estate, filed and those not yet made Biotech Jim-12/12/2012
2816Why would any company in their collective "right mind" purchase YMI, wscaram(o)uche112/12/2012
2815Any justice, and we close green today. $500m for a disabled company shows, IMO, scaram(o)uche-12/12/2012
2814Picked up some more INCY this morning, and if it goes to the 15's I will loaBiotech Jim-12/12/2012
2813Silly that we're down, IMO. A reflection of the breadth of indications withiscaram(o)uche-12/12/2012
2812Gilead Sciences to Acquire YM BioSciences - Adds Selective JAK Inhibitor to Grscaram(o)uche-12/12/2012
2811This might interest some, nothing new, just digging..... clinicaltrials.gov (scaram(o)uche-12/11/2012
2810"The bar is still open." That explains some of those analyst questioscaram(o)uche-12/10/2012
2809SAR30250 phase-2 (dose-ranging) results from ASH: siliconinvestor.comDewDiligence_on_SI-12/9/2012
2808Anybody know the properties of INCB28050 and/or other jak inhibitors re. blood-bscaram(o)uche-12/6/2012
2807ASH abstract...... ash.confex.com "Combination Treatment with JAK2 and PIscaram(o)uche-11/21/2012
2806BKM120 (pan-PI3K inhibitor), which several of us know from the Array/Novartis coscaram(o)uche-11/21/2012
2805cool, and good luck to Dr. Oh and collabortors..... clinicaltrials.govscaram(o)uche-11/21/2012
2804Thanks, Sales.... so, it's a "reasonable speculation" that 110 is scaram(o)uche-11/15/2012
2803Rick, in today's jefferies' presentation q&a, friedman made some csoftware salesperson-11/15/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News